Step 1 of 2
Generalized myasthenia gravis presents ongoing treatment challenges, particularly for patients with persistent symptoms despite standard therapies. In these downloadable slides, explore the role of complement inhibition, review clinical evidence for approved and investigational C5 inhibitors, and examine practical considerations for individualized treatment selection, safety, adherence, and long-term patient-centered care.